Cilastatin

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1315 publications

Plasma and intrapulmonary pharmacokinetics of funobactam, a novel diazabicyclooctane β-lactamase inhibitor, administered in combination with imipenem/cilastatin in healthy subjects.

Plasma and intrapulmonary pharmacokinetics of funobactam, a novel diazabicyclooctane β-lactamase inhibitor, administered in combination with imipenem/cilastatin in healthy subjects.

Journal: Antimicrobial agents and chemotherapy

Published: June 15, 2026

Isolation and functional characterization of primary human proximal tubular epithelial cells from brain-dead organ donors.

Isolation and functional characterization of primary human proximal tubular epithelial cells from brain-dead organ donors.

Journal: Physiological reports

Published: April 19, 2026

Microbiological eradication of XDR Acinetobacter baumannii intra-abdominal infection using sulbactam-durobactam: clinical and microbiological outcomes amidst irreversible host comorbidities.

Microbiological eradication of XDR Acinetobacter baumannii intra-abdominal infection using sulbactam-durobactam: clinical and microbiological outcomes amidst irreversible host comorbidities.

Journal: Frontiers in medicine

Published: March 24, 2026

Successful treatment with clofazimine for macrolide-resistant Mycobacterium abscessus infection in a peritoneal dialysis patient: A case report and literature review.

Successful treatment with clofazimine for macrolide-resistant Mycobacterium abscessus infection in a peritoneal dialysis patient: A case report and literature review.

Journal: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis

Published: March 16, 2026

Feasibility verification of fingerstick capillary microsampling replacing venipuncture for therapeutic drug monitoring of 12 antibiotics using a rapid LC-MS/MS assay.

Feasibility verification of fingerstick capillary microsampling replacing venipuncture for therapeutic drug monitoring of 12 antibiotics using a rapid LC-MS/MS assay.

Journal: Talanta

Published: February 25, 2026

Therapeutic effect of cilastatin administration in LPS-induced retinotoxicity.

Therapeutic effect of cilastatin administration in LPS-induced retinotoxicity.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: February 17, 2026

Imipenem/cilastatin/relebactam dosing regimen justification using exposure-efficacy analyses in participants with hospital-acquired bacterial pneumonia or ventilator-associated bacterial pneumonia in the RESTORE-IMI 2 phase 3 study.

Imipenem/cilastatin/relebactam dosing regimen justification using exposure-efficacy analyses in participants with hospital-acquired bacterial pneumonia or ventilator-associated bacterial pneumonia in the RESTORE-IMI 2 phase 3 study.

Journal: Antimicrobial agents and chemotherapy

Published: January 26, 2026

Case Report: A rare culprit of severe pulmonary infection in children: prevotella.

Case Report: A rare culprit of severe pulmonary infection in children: prevotella.

Journal: Frontiers in pediatrics

Published: January 06, 2026

Development of a novel LC-MS/MS method for concurrent determination of imipenem, relebactam, and cilastatin in human serum, urine and peritoneal drainage fluid.

Development of a novel LC-MS/MS method for concurrent determination of imipenem, relebactam, and cilastatin in human serum, urine and peritoneal drainage fluid.

Journal: BMC chemistry

Published: December 13, 2025

Gentamicin triggers fatty acid oxidation-dependent mitochondrial ROS, driving greater nephrotoxicity than apramycin and other aminoglycosides.

Gentamicin triggers fatty acid oxidation-dependent mitochondrial ROS, driving greater nephrotoxicity than apramycin and other aminoglycosides.

Journal: Free radical biology & medicine

Published: December 10, 2025

Efficacy and safety of cefepime-nacubactam and aztreonam-nacubactam compared with imipenem-cilastatin for complicated urinary tract infection or acute uncomplicated pyelonephritis (Integral-1): a double-blind, randomised phase 3 trial.

Efficacy and safety of cefepime-nacubactam and aztreonam-nacubactam compared with imipenem-cilastatin for complicated urinary tract infection or acute uncomplicated pyelonephritis (Integral-1): a double-blind, randomised phase 3 trial.

Journal: Lancet (London, England)

Published: November 19, 2025

Hospital wastewater as a hotspot for environmental dissemination of a carbapenem representative and enzyme inhibitors: insights from a multi-hospital study.

Hospital wastewater as a hotspot for environmental dissemination of a carbapenem representative and enzyme inhibitors: insights from a multi-hospital study.

Journal: Environmental pollution (Barking, Essex : 1987)

Published: November 13, 2025

Showing 1-12 of 1,315

Last Updated: 06/30/2026